United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014

@article{Sherrard2014UnitedKN,
  title={United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014},
  author={Jackie Sherrard and Catherine A. Ison and Judith Moody and Emma Wainwright and Janet D. Wilson and Ann K Sullivan},
  journal={International Journal of STD \& AIDS},
  year={2014},
  volume={25},
  pages={541 - 549}
}
The main objective is to assist practitioners in managing men and women diagnosed with Trichomonas vaginalis (TV) infection. This guideline offers recommendations on the diagnostic tests, treatment regimens and health promotion principles needed for the effective management of TV, covering the management of the initial presentation, as well as how to prevent transmission and future infection. 
Editorial commentary: Trichomonas vaginalis testing and screening in a high-risk population: is this a glimpse into the future?
  • Stephanie N. Taylor
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2014
TLDR
It is concluded that TV infections would have been missed in one-third of women in the absence of TV testing and screening, and this new information could potentially lead to removal of the TV designation as the “neglected” sexually transmitted infection. Expand
A case of metronidazole-resistant Trichomonas vaginalis in pregnancy
TLDR
The case of a patient with presumed resistant infection during pregnancy is presented, and the additional treatment issues that this presented. Expand
Intravaginal boric acid: is it an alternative therapeutic option for vaginal trichomoniasis?
TLDR
If shown to be safe and effective, intravaginal boric acid might provide a well-tolerated alternative anti-infective treatment which reduces community exposure to systemic antibiotics. Expand
Management of vaginal discharge
TLDR
It is imperative to assess patients thoroughly for accurate diagnoses and appropriate management of patients with vaginal discharge, both non-sexually as well as sexually transmitted. Expand
Trichomonas vaginalis: an audit of clinical practice and the demography of infected patients at three London genitourinary medicine clinics
TLDR
Wet microscopy and liquid medium cultures were both important in identifying the infection, but more needs to be done to ensure partner notification has been documented and contacts have been treated. Expand
Time to re-evaluate the guidance on sexual infections in fertility services
TLDR
Current STI trends, evidence available for STI effect on fertility and new diagnostic methods of screening are outlined and it is demonstrated that UK guidance should be updated and directed towards areas where further research is required. Expand
CCS02.1 Dequalinium chloride vaginal tablets for recalcitrant trichomonas vaginalis (TV): a case report
TLDR
Prolonged dequalinium may offer an alternative treatment option for recalcitrant TV, particularly where high dose systemic antibiotics have been unsuccessful. Expand
Trichomonas vaginalis: Clinical relevance, pathogenicity and diagnosis
TLDR
Investigation of the commercial release of a number of nucleic acid amplification tests (NAATs) has added to the available diagnostic options, and a recent initial evaluation of a NAAT Point of Care system has given promising results, which would enable testing and treatment in a single visit. Expand
Diagnóstico rápido de las infecciones de transmisión sexual
Sexually transmitted infections (STIs) are responsible for an enormous burden of morbidity and mortality. Worldwide, millions of cases of STIs, such as syphilis, chlamydia, or gonorrhoea occur everyExpand
In response to ‘Successful treatment of refractory Trichomonas vaginalis infection using intravenous metronidazole’ by Hawkins et al.
TLDR
The limited evidence to endorse the use of intravenous metronidazole for treatment of refractory Trichomonas vaginalis (TV) infection but had exhausted all other options is acknowledged. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 103 REFERENCES
Prevalence of Trichomonas vaginalis Isolates with Resistance to Metronidazole and Tinidazole
TLDR
Clinical isolates of Trichomonas vaginalis were obtained from women consecutively enrolled in a study of partner notification and in vitro resistance was poorly correlated with clinical response to treatment. Expand
Treatment of metronidazole-resistant Trichomonas vaginalis.
TLDR
A 58-year-old Caucasian woman presented with a 14-month history of persistent trichomoniasis not responsive to numerous courses of metronidazoles and tinidazole and was treated with topical furazolidone and experienced a complete symptomatic cure. Expand
Treatment failure of vaginal trichomoniasis in clinical practice
TLDR
A standardized treatment algorithm using a high dose of metronidazole may be useful in the absence of any new, efficacious non-imidazoles-based TV therapy in the clinical management of persistent TV infection. Expand
Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis.
TLDR
If a purulent, frothy discharge is used as the sole diagnostic criterion, 88% of women with trichomonal vaginitis will not be identified and 29% will be erroneously diagnosed as infected, according to a study at the DeKalb County Georgia, Veneral Disease Clinic. Expand
Interventions for treating trichomoniasis in women.
TLDR
Parasitological cure can be achieved by single oral dose of nitroimidazoles in women with trichomoniasis, and partner treatment can be effective in decreasing longer term reinfection rates. Expand
Interventions for trichomoniasis in pregnancy.
TLDR
Metronidazole, given as a single dose, is likely to provide parasitological cure for trichomonas, but it is not known whether this treatment will have any effect on pregnancy outcomes. Expand
Single-dose metronidazole for trichomonal vaginitis: patient and consort.
  • J. R. Dykers
  • Medicine
  • American journal of obstetrics and gynecology
  • 1978
TLDR
The current recommended regimen for treating trichomonal vaginitis is metronidazole, 250 mg by mouth three times a day for 10 days, according to the US Food and Drug Administration. Expand
Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity.
TLDR
Metronidazole desensitization was effective in the management of women with nitroimidazoles hypersensitivity, and five of 17 infections were eradicated. Expand
Evaluation of the OSOM Trichomonas Rapid Test versus Wet Preparation Examination for Detection of Trichomonas vaginalis Vaginitis in Specimens from Women with a Low Prevalence of Infection
TLDR
OSOM Trich had very good performance, with sensitivity, specificity, efficiency, positive predictive value, and negative predictive value of 94.7, 100, 99.9, and 100.9%, respectively. Expand
Evaluation of polymerase chain reaction assays for the diagnosis of Trichomonas vaginalis infection in Russia
TLDR
This work has shown that in Russia, the microscopy‐ and culture‐based diagnostics of trichomoniasis is mainly suboptimal and any evaluation of these PCRs has never been internationally reported. Expand
...
1
2
3
4
5
...